This is an old revision of the document!
Janssen
Janssen Pharmaceuticals is a pharmaceutical company located in Beerse, Belgium that is wholly owned by multinational corporation Johnson & Johnson.1)
COVID-19
Janssen is part of the COVID-19 Therapeutics Accelerator funded by the Bill & Melinda Gates Foundation, Wellcome Trust, and Mastercard to “accelerate treatments, vaccines, and diagnostics”.2)
Ad26.COV2.S Vaccine
Janssen is distributing a recombinant “non replicating viral vector” COVID-19 vaccine product in the United States and other countries worldwide.3) 4) It is approved but not widely distributed in Canada.5)
1)
DeBree, C. S. (2011, June 22). Centocor is now Janssen Biotech. The Intelligencer. https://archive.ph/eBzXM
2)
Global pharma industry unites behind COVID-19 Therapeutics Accelerator. (2020, March 26). The Pharma Letter. https://www.thepharmaletter.com/article/global-pharma-industry-unites-behind-covid-19-therapeutics-accelerator
3)
Janssen (Johnson & Johnson): Ad26.COV2.S. COVID-19 Vaccine Tracker. Retrieved January 18, 2022, from https://archive.ph/nPhNi
4)
National Center for Immunization and Respiratory Diseases. (2021, November 4). Administration Overview for Johnson & Johnson’s Janssen COVID-19 Vaccine. U.S. Centers for Disease Control and Prevention (CDC). Retrieved December 5, 2021, from https://archive.ph/svpaI
5)
Health Canada. (2021, March 5). Janssen COVID-19 Vaccine. Government of Canada. Retrieved December 5, 2021, from https://archive.ph/2cl9Z